Trial Outcomes & Findings for Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa (NCT NCT01954264)
NCT ID: NCT01954264
Last Updated: 2020-01-21
Results Overview
PFP = measurement of parasite prevalence (PP) by center according to joint technical expert group (JTEG). Centers: Nouna-Burkina Faso (NOU-BF), Ouagadougou-Burkina Faso (OUA-BF), Keur Soce \[Dakar area)-Senegal (DA-1-SE), Naikhar (Dakar area)-Senegal (DA-2-SE). A subject was defined as infected by P. falciparum parasitemia, if at least two of the subject's blood slide readings were positive for the corresponding parasitemia.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
2421 participants
Primary outcome timeframe
At Epoch 1 (Survey visit) (approximately 35 days)
Results posted on
2020-01-21
Participant Flow
Participant milestones
| Measure |
Overall Study Group
Subjects aged between 6 months to 9 years old, who were infected or not infected with Plasmodium falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
|---|---|
|
Overall Study
STARTED
|
2421
|
|
Overall Study
COMPLETED
|
2421
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Overall Study Group
n=2421 Participants
Subjects aged between 6 months to 9 years old, who were infected or not infected with Plasmodium falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
|---|---|
|
Age, Continuous
|
4.0 Years
STANDARD_DEVIATION 2.7 • n=2421 Participants
|
|
Sex: Female, Male
Female
|
1155 Participants
n=2421 Participants
|
|
Sex: Female, Male
Male
|
1266 Participants
n=2421 Participants
|
PRIMARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol (ATP) cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
PFP = measurement of parasite prevalence (PP) by center according to joint technical expert group (JTEG). Centers: Nouna-Burkina Faso (NOU-BF), Ouagadougou-Burkina Faso (OUA-BF), Keur Soce \[Dakar area)-Senegal (DA-1-SE), Naikhar (Dakar area)-Senegal (DA-2-SE). A subject was defined as infected by P. falciparum parasitemia, if at least two of the subject's blood slide readings were positive for the corresponding parasitemia.
Outcome measures
| Measure |
0.5-4Y Group
n=1614 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=807 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), by Study Center
NOU-BF
|
235 Participants
|
153 Participants
|
—
|
—
|
—
|
|
Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), by Study Center
OUA-BF
|
167 Participants
|
141 Participants
|
—
|
—
|
—
|
|
Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), by Study Center
DA-1-SE
|
2 Participants
|
1 Participants
|
—
|
—
|
—
|
|
Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), by Study Center
DA-2-SE
|
5 Participants
|
3 Participants
|
—
|
—
|
—
|
|
Number of Subjects With Plasmodium Falciparum (P. Falciparum) Parasitaemia (PFP), by Study Center
Total
|
409 Participants
|
298 Participants
|
—
|
—
|
—
|
PRIMARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
MCI = measurement of residual spraying, mosquito net usage, seasonal malaria chemoprevention (SMC), intermittent preventative treatment in infants (IPTi) and Artemisinin-based combination therapy (ACT) - therapy received within the last 14 days as indicator of malaria transmission intensity (MTI) by center and JTEG according to P. Falciparum infection status. Centers: Nouna-Burkina Faso (NOU-BF), Ouagadougou-Burkina Faso (OUA-BF), Keur Soce \[Dakar area)-Senegal (DA-1-SE), Naikhar (Dakar area)-Senegal (DA-2-SE). Results presented for overall centers by the following characteristics: Use of Mosquito colis over 7 days (UMc \> 7D), Use of Insecticide spray over 7 days (UIs \> 7D), Use of Commercial Repellents over 7 days (UCR \> 7D), Use of Traditional Repellents over 7 days (UTR \> 7D), Use of none of above over 7 days (Una \>7D), Use of indoor residual spray in past 12 months to spray interior walls (Uirs past 12M), Use of indoor residual spray - number of months ago (Uirs-nM)
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
UMc > 7D, Yes
|
122 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
UMc > 7D, Missing/No
|
2299 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
UIs > 7D, Yes
|
65 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
UIs > 7D, Missing/No
|
2356 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
UCR > 7D, Yes
|
12 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
UCR > 7D, Missing/No
|
2409 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
UTR > 7D, Yes
|
278 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
UTR > 7D, Missing/No
|
2143 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Una >7D, Yes
|
1979 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Una >7D, Missing/No
|
442 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs past 12M, Yes
|
89 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs past 12M, Missing/No
|
2332 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [1]
|
0 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [2]
|
60 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [3]
|
8 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [4]
|
1 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [5]
|
0 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [6]
|
1 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [7]
|
0 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [8]
|
0 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [9]
|
18 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM [10]
|
1 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Malaria Control Interventions (MCIs), Overall
Uirs-nM, Missing
|
2332 Participants
|
—
|
—
|
—
|
—
|
PRIMARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
MCI = measurement of residual spraying, mosquito net usage, seasonal malaria chemoprevention (SMC), intermittent preventative treatment in infants (IPTi) and Artemisinin-based combination therapy (ACT) - therapy received within the last 14 days as indicator of malaria transmission intensity (MTI) by center and JTEG according to P. Falciparum infection status. Centers: Nouna-Burkina Faso (NOU-BF), Ouagadougou-Burkina Faso (OUA-BF), Keur Soce \[Dakar area)-Senegal (DA-1-SE), Naikhar (Dakar area)-Senegal (DA-2-SE). Results presented for overall centers by the following characteristics: Use of Mosquito colis over 7 days (UMc \> 7D), Use of Insecticide spray over 7 days (UIs \> 7D), Use of Commercial Repellents over 7 days (UCR \> 7D), Use of Traditional Repellents over 7 days (UTR \> 7D), Use of none of above over 7 days (Una \>7D), Use of indoor residual spray in past 12 months to spray interior walls (Uirs past 12M), Use of indoor residual spray - number of months ago (Uirs-nM)
Outcome measures
| Measure |
0.5-4Y Group
n=707 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=1714 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of Mosquito coils over 7 days
|
39 Participants
|
83 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of insecticide sprays over 7 days
|
15 Participants
|
50 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of commercial repellents over 7 days
|
4 Participants
|
8 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of traditional repellents over 7 days
|
3 Participants
|
275 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of none of the above over 7 days
|
649 Participants
|
1330 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 12 months
|
3 Participants
|
86 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 1 month
|
0 Participants
|
0 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 2 months
|
1 Participants
|
59 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 3 months
|
1 Participants
|
7 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 4 months
|
0 Participants
|
1 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 5 months
|
0 Participants
|
0 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 6 months
|
1 Participants
|
0 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 7 months
|
0 Participants
|
0 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 8 months
|
0 Participants
|
0 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 9 months
|
0 Participants
|
18 Participants
|
—
|
—
|
—
|
|
Number of Subjects Infected With P.Falciparum Parasitemia Receiving Malaria Control Interventions (MCIs), by Infection Status
Use of indoor residual spray in past 10 months
|
0 Participants
|
1 Participants
|
—
|
—
|
—
|
PRIMARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
MCI = measurement of residual spraying, mosquito net usage, SMC, IPTi and ACT - therapy received within the last 14 days as indicator of MTI according to P. falciparum infection status. Note: - There was only the reference category available for 'Use of Traditional Repellents over 7 days': Missing/No - There was only one category available for 'Use of indoor residual spray - number of month ago': 2 Characteristics were as follows: Malaria treatment in past 14 days (Mt past 14D), Numbers of days of malaria treatment (NdMt), Other medication in the past 14 days (Om past 14D), Number of days of other medication (Ndom), Was the subject hospitalized in the last 3 months due to Malaria (Wsh3MM), Subject sleep under a mosquito net night before visit (Ssumnnbv), New net - less than 1 year (Nn \< 1Y), Impregnated bednet (Ib), Pierced/torn bednet (P/tb), How many holes of that size (HS), UMc \> 7D, UIs \> 7D, UCR \> 7D, UTR \> 7D, Una \>7D, Uirs past 12M.
Outcome measures
| Measure |
0.5-4Y Group
n=388 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
MT PAST 14D, YES VS. NO
|
0.323 Unadjusted Odds Ratio
Interval 0.215 to 0.484
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
NDMT, ≥4 DAYS VS. ONGOING
|
0.917 Unadjusted Odds Ratio
Interval 0.051 to 16.494
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
NDMT, 1-3 DAYS VS. ONGOING
|
0.596 Unadjusted Odds Ratio
Interval 0.239 to 1.483
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
OM PAST 14D, YES VS. NO
|
0.563 Unadjusted Odds Ratio
Interval 0.403 to 0.788
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
NDOM, 1-7 DAYS VS. ONGOING
|
1.155 Unadjusted Odds Ratio
Interval 0.643 to 2.077
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
NDOM, ≥8 DAYS VS. ONGOING
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
WSH3MM, YES VS. NO
|
0.612 Unadjusted Odds Ratio
Interval 0.266 to 1.411
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
SSUMNNBV, YES VS. NO
|
0.447 Unadjusted Odds Ratio
Interval 0.165 to 1.216
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
NN < 1Y, YES VS. NO
|
1.952 Unadjusted Odds Ratio
Interval 0.742 to 5.138
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
IB, YES VS. NO
|
0.677 Unadjusted Odds Ratio
Interval 0.13 to 3.521
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
P/TB, YES VS. NO
|
1.360 Unadjusted Odds Ratio
Interval 0.55 to 3.359
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
HS, ≥5 VS. <5
|
0.311 Unadjusted Odds Ratio
Interval 0.046 to 2.11
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
UMC > 7D, YES VS. MISSING/NO
|
1.158 Unadjusted Odds Ratio
Interval 0.631 to 2.125
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
UIS > 7D, YES VS. MISSING/NO
|
0.456 Unadjusted Odds Ratio
Interval 0.225 to 0.924
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
UCR > 7D, YES VS. MISSING/NO
|
0.857 Unadjusted Odds Ratio
Interval 0.142 to 5.169
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
UNA >7D, YES VS. MISSING/NO
|
1.339 Unadjusted Odds Ratio
Interval 0.84 to 2.134
|
—
|
—
|
—
|
—
|
|
Odds Ratio (OR) for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Nouna Center in Burkina Faso
UIRS PAST 12M, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
PRIMARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
MCI = measurement of residual spraying, mosquito net usage, SMC, IPTi and ACT - therapy received within the last 14 days as indicator of MTI according to P. falciparum infection status. Note: - There was only the reference category for 'Use of Insecticide spray over 7 days': Missing/No and 'Use of Traditional Repellents over 7 days': Missing/No - The reference category ('2') for 'Use of indoor residual spray - number of month ago': 2 Characteristics were as follows: Malaria treatment in past 14 days (Mt past 14D), Numbers of days of malaria treatment (NdMt), Other medication in the past 14 days (Om past 14D), Number of days of other medication (Ndom), Was the subject hospitalized in the last 3 months due to Malaria (Wsh3MM), Subject sleep under a mosquito net night before visit (Ssumnnbv), New net - less than 1 year (Nn \< 1Y), Impregnated bednet (Ib), Pierced/torn bednet (P/tb), How many holes of that size (HS), UMc \> 7D, UIs \> 7D, UCR \> 7D, UTR \> 7D, Una \>7D, Uirs past 12M.
Outcome measures
| Measure |
0.5-4Y Group
n=308 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
MT PAST 14D, YES VS. NO
|
0.143 Unadjusted Odds Ratio
Interval 0.066 to 0.308
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
NDMT, ≥4 DAYS VS. ONGOING
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not countable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
NDMT, 1-3 DAYS VS. ONGOING
|
0.341 Unadjusted Odds Ratio
Interval 0.027 to 4.29
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
OM PAST 14D, YES VS. NO
|
0.300 Unadjusted Odds Ratio
Interval 0.171 to 0.529
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
NDOM, 1-7 DAYS VS. ONGOING
|
0.568 Unadjusted Odds Ratio
Interval 0.121 to 2.668
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
NDOM, ≥8 DAYS VS. ONGOING
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not countable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
WSH3MM, YES VS. NO
|
1.146 Unadjusted Odds Ratio
Interval 0.566 to 2.318
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
SSUMNNBV, YES VS. NO
|
0.956 Unadjusted Odds Ratio
Interval 0.51 to 1.791
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
NN < 1Y, YES VS. NO
|
1.163 Unadjusted Odds Ratio
Interval 0.486 to 2.785
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
IB, YES VS. NO
|
0.699 Unadjusted Odds Ratio
Interval 0.116 to 4.214
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
P/TB, YES VS. NO
|
0.376 Unadjusted Odds Ratio
Interval 0.072 to 1.956
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
HS, ≥5 VS. <5
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not countable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
UMC > 7D, YES VS. MISSING/NO
|
3.829 Unadjusted Odds Ratio
Interval 0.425 to 34.458
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
UIS > 7D, YES VS. MISSING/NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not countable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
UCR > 7D, YES VS. MISSING/NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not countable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
UTR > 7D, NOT PERFORMED
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not countable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
UNA >7D, YES VS. MISSING/NO
|
0.208 Unadjusted Odds Ratio
Interval 0.024 to 1.793
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Ouagadougu Center in Burkina Faso
UIRS PAST 12M, YES VS. NO
|
0.948 Unadjusted Odds Ratio
Interval 0.133 to 6.772
|
—
|
—
|
—
|
—
|
PRIMARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
MCI = measurement of residual spraying, mosquito net usage, SMC, IPTi and ACT - therapy received within the last 14 days as indicator of MTI according to P. falciparum infection status. Note: - There was only one category available for 'Exact number of days of malaria treatment':1-3 days, 'Use of Indoor residual spray - numbers of months ago': 9, 'Use of Commercial Repellents over 7 days': Missing/No - There were not enough values in the reference category ('\<5') to compute the OR for HS. Characteristics were as follows: Malaria treatment in past 14 days (Mt past 14D), Other medication in the past 14 days (Om past 14D), Number of days of other medication (Ndom), Was the subject hospitalized in the last 3 months due to Malaria (Wsh3MM), Subject sleep under a mosquito net night before visit (Ssumnnbv), New net - less than 1 year (Nn \< 1Y), Impregnated bednet (Ib), Pierced/torn bednet (P/tb), UMc \> 7D, UIs \>7D, UCR \> 7D, UTR \> 7D, Una \>7D.
Outcome measures
| Measure |
0.5-4Y Group
n=3 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
MT PAST 14D, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
OM PAST 14D, YES VS. NO
|
7.395 Unadjusted Odds Ratio
Interval 0.656 to 83.396
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
NDOM, ≥ 8 days vs. Ongoing
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
NDOM, 1-7 days vs. Ongoing
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
WSH3MM, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
SSUMNNBV, YES VS. NO
|
0.948 Unadjusted Odds Ratio
Interval 0.085 to 10.523
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
NN < 1Y, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
IB, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
P/TB, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
UMC > 7D, YES VS. MISSING/NO
|
5.383 Unadjusted Odds Ratio
Interval 0.48 to 60.381
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
UIS > 7D, YES VS. MISSING/NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
UTR > 7D, YES VS. MISSING/NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
UNA >7D, YES VS. MISSING/NO
|
0.484 Unadjusted Odds Ratio
Interval 0.044 to 5.387
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Keur Soce Center in Dakar Area in Senegal
UIRS PAST 12M, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
PRIMARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
MCI = measurement of residual spraying, mosquito net usage, SMC, IPTi and ACT - therapy received within the last 14 days as indicator of MTI according to P. falciparum infection status. Note: - There was only one category available for 'Exact number of days of malaria treatment':1-3 days and 'How many holes of that size': ≥5. Characteristics were as follows: Malaria treatment in past 14 days (Mt past 14D), Numbers of days of malaria treatment (NdMt), Other medication in the past 14 days (Om past 14D), Number of days of other medication (Ndom), Was the subject hospitalized in the last 3 months due to Malaria (Wsh3MM), Subject sleep under a mosquito net night before visit (Ssumnnbv), New net - less than 1 year (Nn \< 1Y), Impregnated bednet (Ib), Pierced/torn bednet (P/tb), How many holes of that size (HS), UMc \> 7D, UIs \> 7D, UCR \> 7D, UTR \> 7D, Una \>7D, Uirs past 12M.
Outcome measures
| Measure |
0.5-4Y Group
n=8 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
MT PAST 14D, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
OM PAST 14D, YES VS. N
|
2.652 Unadjusted Odds Ratio
Interval 0.525 to 13.404
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
NDOM, 1-7 DAYS VS. ONGOING
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
NDOM, ≥8 DAYS VS. ONGOING
|
0.340 Unadjusted Odds Ratio
Interval 0.02 to 5.764
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
WSH3MM, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
SSUMNNBV, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
NN < 1Y, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
IB, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
P/TB, YES VS. NO
|
0.779 Unadjusted Odds Ratio
Interval 0.184 to 3.299
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
UMC > 7D, YES VS. MISSING/NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
UIS > 7D, YES VS. MISSING/NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
UCR > 7D, YES VS. MISSING/NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
UTR > 7D, Yes vs. Missing/NO
|
1.007 Unadjusted Odds Ratio
Interval 0.238 to 4.255
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
UNA >7D, YES VS. MISSING/NO
|
1.036 Unadjusted Odds Ratio
Interval 0.245 to 4.375
|
—
|
—
|
—
|
—
|
|
Odds Ratio for the Number of Subjects With MCI, Infected With P. Falciparum Parasitemia, for the Niakhar Center in Dakar Area in Senegal
UIRS PAST 12M, YES VS. NO
|
NA Unadjusted Odds Ratio
Unadjusted OR value was not computable.
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The medical history characteristics were as follows: -subject sleep under a mosquito net night before visit (Ssumnnbv), New net - less than 1 year (Nn \< 1Y), Impregnated Bednet (Ib), Pierced/torn bednet (P/tb), How many holes of that size (HS).
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With Other Medical History Characteristics, Overall
SSUMNNBV, YES
|
2023 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
SSUMNNBV, NO
|
398 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
NN < 1Y, YES
|
1591 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
NN < 1Y, NO
|
431 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
NN < 1Y, MISSING/NA
|
399 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
IB, YES
|
1618 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
IB, NO
|
405 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
IB, MISSING/NA
|
398 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
P/TB, YES
|
406 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
P/TB, NO
|
1617 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
P/TB, MISSING/NA
|
398 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
HS < 5
|
17 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
HS ≥ 5
|
389 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Other Medical History Characteristics, Overall
HS, MISSING/NA
|
2015 Participants
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The annual age extended over a 0 year-9 years range. The age characteristics were summarized by P. falciparum infection status.
Outcome measures
| Measure |
0.5-4Y Group
n=707 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=1714 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
0 years olds
|
48 Participants
|
202 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
1 year olds
|
98 Participants
|
380 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
2 year olds
|
131 Participants
|
348 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
3 year olds
|
71 Participants
|
136 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
4 year olds
|
61 Participants
|
139 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
5 year olds
|
55 Participants
|
106 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
6 year olds
|
53 Participants
|
109 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
7 year olds
|
59 Participants
|
104 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
8 year olds
|
66 Participants
|
92 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Age, According to P. Falciparum Infection Status
9 year olds
|
65 Participants
|
98 Participants
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The JTEG categorisation referred to the distribution of subjects by different age groups: 6 months to 4 years of age inclusive (0.5Y-4Y category) and 5 to 9 years of age inclusive (5-9Y category), tabulated according to P. falciparum infection status.
Outcome measures
| Measure |
0.5-4Y Group
n=707 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=1714 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects by JTEG Age Group, According to P. Falciparum Infection Status
0.5Y - 4Y
|
409 Participants
|
1205 Participants
|
—
|
—
|
—
|
|
Number of Subjects by JTEG Age Group, According to P. Falciparum Infection Status
5Y - 9Y
|
298 Participants
|
509 Participants
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The gender characteristics were summarized by P. falciparum infection status.
Outcome measures
| Measure |
0.5-4Y Group
n=707 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=1714 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects by Gender, According to P. Falciparum Infection Status
Female
|
337 Participants
|
818 Participants
|
—
|
—
|
—
|
|
Number of Subjects by Gender, According to P. Falciparum Infection Status
Male
|
370 Participants
|
896 Participants
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
Other Plasmodium species included: P. Malariae, P. Vivax, P. Ovale with Negative and Positive results. A subjects was defined as infected by a specified parasitemia if at least two of the subject's blood slide readings were positive for the corresponding parasitemia. The results were tabulated according to JTEG age categorisation.
Outcome measures
| Measure |
0.5-4Y Group
n=1614 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=807 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With Plasmodium Species Other Than P. Falciparum, by JTEG Age Group and Per Total Centers
P. Malariae, Positive
|
23 Participants
|
32 Participants
|
—
|
—
|
—
|
|
Number of Subjects With Plasmodium Species Other Than P. Falciparum, by JTEG Age Group and Per Total Centers
P. Malariae, Negative
|
1591 Participants
|
775 Participants
|
—
|
—
|
—
|
|
Number of Subjects With Plasmodium Species Other Than P. Falciparum, by JTEG Age Group and Per Total Centers
P. Vivax, Positive
|
0 Participants
|
0 Participants
|
—
|
—
|
—
|
|
Number of Subjects With Plasmodium Species Other Than P. Falciparum, by JTEG Age Group and Per Total Centers
P. Vivax, Negative
|
1614 Participants
|
807 Participants
|
—
|
—
|
—
|
|
Number of Subjects With Plasmodium Species Other Than P. Falciparum, by JTEG Age Group and Per Total Centers
P. Ovale, Positive
|
4 Participants
|
5 Participants
|
—
|
—
|
—
|
|
Number of Subjects With Plasmodium Species Other Than P. Falciparum, by JTEG Age Group and Per Total Centers
P. Ovale, Negative
|
1610 Participants
|
802 Participants
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
Anti-malarial therapy included Malaria treatment (MT) in past 14 days, Other medication (OM) in past 14 days and Malaria hospitalization (MH) in the last 3 months.
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With Anti-malarial Therapy, Overall
MT IN PAST 14 DAYS, YES
|
187 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Anti-malarial Therapy, Overall
MT IN PAST 14 DAYS, NO
|
2234 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Anti-malarial Therapy, Overall
OM IN PAST 14 DAYS, YES
|
419 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Anti-malarial Therapy, Overall
OM IN PAST 14 DAYS, NO
|
2002 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Anti-malarial Therapy, Overall
MH IN THE LAST 3 MONTHS, YES
|
60 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Anti-malarial Therapy, Overall
MH IN THE LAST 3 MONTHS, NO
|
2361 Participants
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The duration of anti-malarial therapy referred to the exact number of days of malaria treatment (EDMT) and the number of days of other medication (DOM). Note: \* In case of several medication (malaria treatment or other medication) taken per subject, the maximum duration was computed for this study.
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Days With Therapy, Overall
EDMT, Ongoing
|
26 Days
|
—
|
—
|
—
|
—
|
|
Number of Days With Therapy, Overall
EDMT, 1-3 days
|
155 Days
|
—
|
—
|
—
|
—
|
|
Number of Days With Therapy, Overall
EDMT, ≥ 4days
|
3 Days
|
—
|
—
|
—
|
—
|
|
Number of Days With Therapy, Overall
EDMT, Missing/NA
|
2237 Days
|
—
|
—
|
—
|
—
|
|
Number of Days With Therapy, Overall
DOM, Ongoing
|
101 Days
|
—
|
—
|
—
|
—
|
|
Number of Days With Therapy, Overall
DOM, 1-7 days
|
310 Days
|
—
|
—
|
—
|
—
|
|
Number of Days With Therapy, Overall
DOM, ≥ 8 days
|
7 Days
|
—
|
—
|
—
|
—
|
|
Number of Days With Therapy, Overall
DOM, Missing/NA
|
2003 Days
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
This endpoint presents results per total centers and across all age categories.
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Days of Malaria Treatment, Overall
|
3.0 Days
Standard Deviation 0.81
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
Characteristics of fever were the following: Fever in the last 24 hours (F 24h) and Fever\* at visit (F\* at V). Note: \*Fever set to Yes if temperature recorded at visit after axillary conversion was ≥ 37.5 ◦C.
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With Fever, Overall
F 24h, Yes
|
331 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Fever, Overall
F 24h, No
|
2090 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Fever, Overall
F* at V, Yes
|
179 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Fever, Overall
F* at V, No
|
2241 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With Fever, Overall
F* at V, Missing
|
1 Participants
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
This endpoint presents results per total centers and across all age categories.
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Days With Fever, Overall
|
3.0 Days
Standard Deviation 2.69
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The malaria prevention and risk factor presented in this endpoint was: Number of persons living in the same part of the house - persons enrolled in the study (PLSPH-PES), in the following combinations: \< y/x, where x are persons enrolled in the study among less than y persons living in the same part of the house, y-z/x, where x are persons enrolled in the study among y to z persons living in the same part of the house, \> z/x, where x persons are enrolled in the study among more than z persons living in the same part of the house, y-z/\> x, where more than x persons enrolled in the study among y to z persons living in the same part of the house, \> z/\> x, where more than x persons enrolled in the study among more than z persons living in the same part of the house.
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, 4-5/2
|
112 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, >5/2
|
214 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, <3/3
|
0 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, 4-5/3
|
15 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, >5/3
|
42 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, 4-5/>3
|
0 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, >5/>3
|
13 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, <3/1
|
517 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, 4-5/1
|
590 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, >5/1
|
864 Participants
|
—
|
—
|
—
|
—
|
|
Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
PLSPH-PES, <3/2
|
54 Participants
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The malaria prevention and risk factor presented in this endpoint was: Number of persons living in the same part of the house (PLSPH).
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Descriptive Statistics for Number of Persons With P. Falciparum Living in the Same Part of the House of Persons Enrolled in the Study (PLSPH-PES), Overall
|
7.8 Persons Living in Same Part of House
Standard Deviation 6.49
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The malaria prevention and risk factor for this endpoint was: Number of subjects living in the same part of the house - persons enrolled in the study (PLSPH-PES), in the following combinations: \< y/x, where x are persons enrolled in the study among less than y persons living in the same part of the house, y-z/x, where x are persons enrolled in the study among y to z persons living in the same part of the house, \> z/x, where x persons are enrolled in the study among more than z persons living in the same part of the house, y-z/\> x, where more than x persons enrolled in the study among y to z persons living in the same part of the house, \> z/\> x, where more than x persons enrolled in the study among more than z persons living in the same part of the house. Results are presented for the Nouna-Burkina Faso (NOU-BF), Ouagadougou-Burkina Faso (OUA-BF), Keur Soce \[Dakar area)-Senegal (DA-1-SE) and Naikhar (Dakar area)-Senegal (DA-2-SE) centers.
Outcome measures
| Measure |
0.5-4Y Group
n=411 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=164 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
n=70 Participants
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
n=62 Participants
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
n=1714 Participants
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, <3/1
|
85 Participants
|
34 Participants
|
14 Participants
|
11 Participants
|
68 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, 4-5/1
|
86 Participants
|
38 Participants
|
17 Participants
|
8 Participants
|
93 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, >5/1
|
49 Participants
|
22 Participants
|
6 Participants
|
4 Participants
|
57 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, <3/2
|
1 Participants
|
0 Participants
|
1 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, 4-5/2
|
4 Participants
|
2 Participants
|
2 Participants
|
0 Participants
|
4 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, >5/2
|
4 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, <3/3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, 4-5/3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, >5/3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, 4-5/>3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSP-PES, >5/>3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, <3/1
|
67 Participants
|
26 Participants
|
15 Participants
|
16 Participants
|
122 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, 4-5/1
|
44 Participants
|
24 Participants
|
12 Participants
|
14 Participants
|
100 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, >5/1
|
7 Participants
|
3 Participants
|
2 Participants
|
3 Participants
|
17 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, <3/2
|
16 Participants
|
3 Participants
|
0 Participants
|
1 Participants
|
24 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, 4-5/2
|
28 Participants
|
10 Participants
|
0 Participants
|
1 Participants
|
19 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, >5/2
|
5 Participants
|
1 Participants
|
0 Participants
|
1 Participants
|
7 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, <3/3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, 4-5/3
|
7 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
1 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, >5/3
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
2 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, 4-5/>3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSP-PES, >5/>3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, <3/1
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
59 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, 4-5/1
|
1 Participants
|
1 Participants
|
0 Participants
|
1 Participants
|
139 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, >5/1
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
235 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, <3/2
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
8 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, 4-5/2
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
42 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, >5/2
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
92 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, <3/3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, 4-5/3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
6 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, >5/3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
15 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, 4-5/>3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSP-PES, >5/>3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
4 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, <3/1
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, 4-5/1
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
12 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, >5/1
|
6 Participants
|
0 Participants
|
1 Participants
|
0 Participants
|
452 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, <3/2
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, 4-5/2
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, >5/2
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
104 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, <3/3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, 4-5/3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, >5/3
|
0 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
23 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, 4-5/>3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSP-PES, >5/>3
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The malaria prevention and risk factor for this endpoint was: Number of subjects living in the same part of the house (PLSPH). Results are presented for the Nouna-Burkina Faso (NOU-BF), Ouagadougou-Burkina Faso (OUA-BF), Keur Soce \[Dakar area)-Senegal (DA-1-SE) and Naikhar (Dakar area)-Senegal (DA-2-SE) centers.
Outcome measures
| Measure |
0.5-4Y Group
n=411 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=164 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
n=70 Participants
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
n=62 Participants
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
n=1714 Participants
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Descriptive Statistics for Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
NOU-BF, PLSPH
|
4.5 Persons Living in Same Part of House
Standard Deviation 2.29
|
4.6 Persons Living in Same Part of House
Standard Deviation 2.48
|
4.2 Persons Living in Same Part of House
Standard Deviation 1.30
|
4.2 Persons Living in Same Part of House
Standard Deviation 1.68
|
4.7 Persons Living in Same Part of House
Standard Deviation 2.21
|
|
Descriptive Statistics for Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
OUA-BF, PLSPH
|
3.8 Persons Living in Same Part of House
Standard Deviation 1.21
|
3.8 Persons Living in Same Part of House
Standard Deviation 1.20
|
3.7 Persons Living in Same Part of House
Standard Deviation 1.14
|
3.7 Persons Living in Same Part of House
Standard Deviation 1.45
|
3.8 Persons Living in Same Part of House
Standard Deviation 1.23
|
|
Descriptive Statistics for Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-1-SE, PLSPH
|
5.0 Persons Living in Same Part of House
Standard Deviation 0.00
|
5.0 Persons Living in Same Part of House
Standard Deviation 0.00
|
NA Persons Living in Same Part of House
Standard Deviation NA
No results were available with the specified criteria.
|
4.0 Persons Living in Same Part of House
Standard Deviation 0.00
|
8.0 Persons Living in Same Part of House
Standard Deviation 4.94
|
|
Descriptive Statistics for Subjects With Different P. Falciparum Parasite Densities, Living in the Same House, by Center
DA-2-SE, PLSPH
|
16.2 Persons Living in Same Part of House
Standard Deviation 5.91
|
NA Persons Living in Same Part of House
Standard Deviation NA
No results were available with the specified criteria.
|
9.0 Persons Living in Same Part of House
Standard Deviation 0.00
|
9.0 Persons Living in Same Part of House
Standard Deviation 0.00
|
15.0 Persons Living in Same Part of House
Standard Deviation 7.73
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The malaria prevention and risk factor characteristics for this endpoint were the following: Situation area (rural, urban, semi-rural) and Type of Location\*. Note: \*Large city = \>1 million habitants; Small city = \>50000 \& \< 1 million habitants ; Town = \> 10000 and \< 50000 habitants; Countryside = \< 10000 habitants.
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With P. Falciparum by Situation Area, Overall
Situation area, Rural
|
2127 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by Situation Area, Overall
Situation area, Urban
|
294 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by Situation Area, Overall
Situation area, Semi-rural
|
0 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by Situation Area, Overall
Type of Location, Large city
|
14 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by Situation Area, Overall
Type of Location, Small city
|
0 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by Situation Area, Overall
Type of Location, Town
|
282 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by Situation Area, Overall
Type of Location, Countryside
|
2125 Participants
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The malaria prevention and risk factor characteristics were the following: Situation area (urban, rural, semi-rural) and Type of Location\*. Note: \*Large city = \>1 million habitants; Small city = \>50000 \& \< 1 million habitants ; Town = \> 10000 and \< 50000 habitants; Countryside = \< 10000 habitants. Results are presented for the Nouna-Burkina Faso (NOU-BF), Ouagadougou-Burkina Faso (OUA-BF), Keur Soce \[Dakar area)-Senegal (DA-1-SE) and Naikhar (Dakar area)-Senegal (DA-2-SE) centers.
Outcome measures
| Measure |
0.5-4Y Group
n=411 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=164 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
n=70 Participants
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
n=62 Participants
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
n=1714 Participants
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
NOU-BF, Situation area, Rural
|
129 Participants
|
71 Participants
|
23 Participants
|
16 Participants
|
84 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
NOU-BF, Situation area, Urban
|
100 Participants
|
25 Participants
|
17 Participants
|
7 Participants
|
138 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
NOU-BF, Situation area, semi-rural
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
NOU-BF, Type of Location, Large city
|
0 Participants
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
NOU-BF, Type of Location, Small city
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
NOU-BF, Type of Location, Town
|
97 Participants
|
25 Participants
|
16 Participants
|
7 Participants
|
135 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
NOU-BF, Type of Location, Countryside
|
132 Participants
|
70 Participants
|
24 Participants
|
16 Participants
|
87 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
OUA-BF, Situation area, Rural
|
174 Participants
|
67 Participants
|
27 Participants
|
37 Participants
|
289 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
OUA-BF, Situation area, Urban
|
1 Participants
|
0 Participants
|
2 Participants
|
0 Participants
|
3 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
OUA-BF, Situation area, semi-rural
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
OUA-BF, Type of Location, Large city
|
2 Participants
|
0 Participants
|
1 Participants
|
0 Participants
|
5 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
OUA-BF, Type of Location, Small city
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
OUA-BF, Type of Location, Town
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
OUA-BF, Type of Location, Countryside
|
173 Participants
|
67 Participants
|
28 Participants
|
37 Participants
|
287 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-1-SE, Situation area, Rural
|
1 Participants
|
1 Participants
|
0 Participants
|
1 Participants
|
600 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-1-SE, Situation area, Urban
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-1-SE, Situation area, semi-rural
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-1-SE, Type of Location, Large city
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
5 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-1-SE, Type of Location, Small city
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-1-SE, Type of Location, Town
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-1-SE, Type of Location, Countryside
|
1 Participants
|
1 Participants
|
0 Participants
|
1 Participants
|
595 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-2-SE, Situation area, Rural
|
6 Participants
|
0 Participants
|
1 Participants
|
1 Participants
|
599 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-2-SE, Situation area, Urban
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-2-SE, Situation area, semi-rural
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-2-SE, Type of Location, Large city
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-2-SE, Type of Location, Small city
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-2-SE, Type of Location, Town
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
2 Participants
|
|
Number of Subjects With Different P. Falciparum Densities by Situation Area and Center
DA-2-SE, Type of Location, Countryside
|
6 Participants
|
0 Participants
|
1 Participants
|
1 Participants
|
598 Participants
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The malaria prevention and risk factor characteristics for this endpoint were the following: - Main house construction material (MHCM) walls, floor, roof, windows/eaves, nets; - Main source of drinking water (MSDW); - Presence of electricity (PE). Note: \*Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. % Closed water source (piper water, tube well, dug well, protected well); Open water source (unprotected well, spring water, rainwater, tanker truck, surface water).
Outcome measures
| Measure |
0.5-4Y Group
n=2421 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM walls, mud
|
1176 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM walls, brick
|
728 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM walls, cement/plaster
|
140 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM walls, cement/paint
|
365 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM walls, other
|
12 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM floor, natural floor*
|
1283 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM floor, rudimentary floor*
|
16 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM floor, vinyl oe asphalt strips
|
95 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM floor, ceramic tiles
|
43 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM floor, cement
|
980 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM floor, carpet
|
3 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM floor, other
|
1 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM roof, glass/palm
|
632 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM roof, iron sheet
|
1493 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM roof, tiles
|
290 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM roof, missing
|
6 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM windows/eaves, closed
|
968 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM windows/eaves, open
|
653 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM windows/eaves, partially open
|
405 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM windows/eaves, missing
|
395 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM nets, not present
|
2005 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM nets, present on all windows
|
16 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM nets, present on some windows
|
6 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MHCM nets, missing
|
394 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MSDW, bottled water
|
2 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MSDW, closed water source %
|
1706 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MSDW, open water source %
|
712 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
MSDW, not applicable
|
1 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
PE, Yes
|
361 Participants
|
—
|
—
|
—
|
—
|
|
Number of Subjects With P. Falciparum by House Construction Material and Other House Information, Overall
PE, No
|
2060 Participants
|
—
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: At Epoch 1 (Survey visit) (approximately 35 days)Population: The According to Protocol cohort included all evaluable subjects for whom at least one laboratory result of the blood sample was available.
The malaria prevention and risk factor characteristics for this endpoint were the following: - Main house construction material (MHCM) walls, floor, roof, windows/eaves, nets; - Main source of drinking water (MSDW); - Presence of electricity (PE). Natural floor = earth, sand, dung; Rudimentary floor = wood planks, palm, bamboo. Closed water source = pipe water, tube well, dug well, protected well; Open water source = unprotected well, spring water, rainwater, tanker truck, surface water. Results are presented for the Nouna-Burkina Faso (NOU-BF), Ouagadougou-Burkina Faso (OUA-BF), Keur Soce \[Dakar area)-Senegal (DA-1-SE) and Naikhar (Dakar area)-Senegal (DA-2-SE) centers.
Outcome measures
| Measure |
0.5-4Y Group
n=411 Participants
Subjects aged 6 months to 4 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
5-9Y Group
n=164 Participants
Subjects aged 5 to 9 years (Y) old, who were infected or not infected with P. falciparum parasite. Infection status was assessed using a blood smear slide and determined using microscopy.
|
High PD Group
n=70 Participants
Subjects aged between 6 months to 9 years old, with high P. falciparum parasite density (10000 - 19999 parasite per µL).
|
Vhigh PD Group
n=62 Participants
Subjects aged between 6 months to 9 years old, with very high P. falciparum parasite density (≥20000 parasite per µL).
|
Neg PD Group
n=1714 Participants
Subjects aged between 6 months to 9 years old, who were not infected with P. falciparum parasite.
|
|---|---|---|---|---|---|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, brick : OUA-BF
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
6 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, cement/plaster : DA-2-SE
|
2 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
114 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, brick : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
210 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, mud : NOU-BF
|
49 Participants
|
18 Participants
|
4 Participants
|
6 Participants
|
52 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, mud : OUA-BF
|
174 Participants
|
67 Participants
|
29 Participants
|
37 Participants
|
283 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, mud : DA-1-SE
|
1 Participants
|
1 Participants
|
0 Participants
|
1 Participants
|
170 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, mud : DA-2-SE
|
4 Participants
|
0 Participants
|
1 Participants
|
0 Participants
|
279 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, brick : NOU-BF
|
153 Participants
|
70 Participants
|
32 Participants
|
17 Participants
|
129 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, brick : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
110 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, cement/plaster : NOU-BF
|
6 Participants
|
1 Participants
|
1 Participants
|
0 Participants
|
12 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, cement/plaster : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
3 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, cement/paint : NOU-BF
|
21 Participants
|
5 Participants
|
3 Participants
|
0 Participants
|
29 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, cement/paint : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, cement/paint : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
220 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, cement/plaster : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, cement/paint : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
87 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, other : NOU-BF
|
0 Participants
|
2 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, other : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, other : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM walls, other : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
10 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, natural floor : NOU-BF
|
114 Participants
|
66 Participants
|
17 Participants
|
11 Participants
|
90 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, natural floor : OUA-BF
|
156 Participants
|
57 Participants
|
25 Participants
|
32 Participants
|
255 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, natural floor : DA-1-SE
|
1 Participants
|
1 Participants
|
0 Participants
|
1 Participants
|
118 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, natural floor : DA-2-SE
|
0 Participants
|
0 Participants
|
1 Participants
|
1 Participants
|
332 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, rudimentary floor : NOU-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, rudimentary floor : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, rudimentary floor : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, rudimentary floor : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
16 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, vinyl or asphalt strips : NOU-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, vinyl or asphalt strips : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, vinyl or asphalt strips : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
95 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, vinyl or asphalt strips : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, ceramic tiles : NOU-BF
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
3 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, ceramic tiles : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, ceramic tiles : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
36 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, ceramic tiles : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
3 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, cement : NOU-BF
|
114 Participants
|
30 Participants
|
23 Participants
|
12 Participants
|
129 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, cement : OUA-BF
|
19 Participants
|
10 Participants
|
4 Participants
|
5 Participants
|
37 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, cement : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
349 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, cement : DA-2-SE
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
247 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, carpet : NOU-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, carpet : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, carpet : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
2 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, carpet : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, other : NOU-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, other : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, other : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM floor, other : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, glass/palm : NOU-BF
|
5 Participants
|
5 Participants
|
0 Participants
|
0 Participants
|
5 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, glass/palm : OUA-BF
|
52 Participants
|
27 Participants
|
9 Participants
|
12 Participants
|
68 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, glass/palm : DA-1-SE
|
1 Participants
|
1 Participants
|
0 Participants
|
1 Participants
|
100 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, glass/palm : DA-2-SE
|
4 Participants
|
0 Participants
|
1 Participants
|
1 Participants
|
300 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, iron sheet : NOU-BF
|
121 Participants
|
34 Participants
|
21 Participants
|
7 Participants
|
128 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, iron sheet : OUA-BF
|
123 Participants
|
40 Participants
|
20 Participants
|
25 Participants
|
224 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, iron sheet : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
451 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, iron sheet : DA-2-SE
|
2 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
297 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, tiles : NOU-BF
|
103 Participants
|
57 Participants
|
19 Participants
|
16 Participants
|
89 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, tiles : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, tiles : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
3 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM roof, tiles : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
3 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, closed : NOU-BF
|
79 Participants
|
26 Participants
|
16 Participants
|
5 Participants
|
84 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, closed : OUA-BF
|
80 Participants
|
32 Participants
|
17 Participants
|
15 Participants
|
116 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, closed : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
28 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, closed : DA-2-SE
|
5 Participants
|
0 Participants
|
1 Participants
|
1 Participants
|
463 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, open : NOU-BF
|
102 Participants
|
47 Participants
|
10 Participants
|
12 Participants
|
87 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, open : OUA-BF
|
49 Participants
|
12 Participants
|
6 Participants
|
13 Participants
|
90 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, open : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
88 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, open : DA-2-SE
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
136 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, partially open : NOU-BF
|
48 Participants
|
23 Participants
|
14 Participants
|
6 Participants
|
51 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, partially open : OUA-BF
|
46 Participants
|
23 Participants
|
6 Participants
|
9 Participants
|
86 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, partially open : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
92 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM windows/eaves, partially open : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, not present : NOU-BF
|
224 Participants
|
95 Participants
|
40 Participants
|
23 Participants
|
215 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, not present : OUA-BF
|
173 Participants
|
66 Participants
|
29 Participants
|
37 Participants
|
291 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, not present : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
206 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, not present : DA-2-SE
|
6 Participants
|
0 Participants
|
1 Participants
|
1 Participants
|
598 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, present on all windows : NOU-BF
|
4 Participants
|
1 Participants
|
0 Participants
|
0 Participants
|
5 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, present on all windows : OUA-BF
|
1 Participants
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, present on all windows : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
2 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, present on all windows : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
2 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, present on some windows : NOU-BF
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
2 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, present on some windows : OUA-BF
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, present on some windows : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MHCM nets, present on some windows : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, bottled water : NOU-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, bottled water : OUA-BF
|
1 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, bottled water : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, bottled water : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, closed water source : NOU-BF
|
146 Participants
|
57 Participants
|
24 Participants
|
9 Participants
|
116 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, closed water source : OUA-BF
|
152 Participants
|
50 Participants
|
25 Participants
|
31 Participants
|
247 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, closed water source : DA-1-SE
|
1 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
465 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, closed water source : DA-2-SE
|
2 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
379 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, open water source : NOU-BF
|
83 Participants
|
39 Participants
|
16 Participants
|
14 Participants
|
105 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, open water source : OUA-BF
|
22 Participants
|
17 Participants
|
4 Participants
|
6 Participants
|
44 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, open water source : DA-1-SE
|
0 Participants
|
1 Participants
|
0 Participants
|
0 Participants
|
135 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, open water source : DA-2-SE
|
4 Participants
|
0 Participants
|
1 Participants
|
0 Participants
|
221 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, not applicable : NOU-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
1 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, not applicable : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, not applicable : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
MSDW, not applicable : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
PE, Yes : NOU-BF
|
46 Participants
|
11 Participants
|
7 Participants
|
3 Participants
|
76 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
PE, Yes : OUA-BF
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
PE, Yes : DA-1-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
164 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
PE, Yes : DA-2-SE
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
PE, No : NOU-BF
|
183 Participants
|
85 Participants
|
33 Participants
|
20 Participants
|
146 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
PE, No : OUA-BF
|
175 Participants
|
67 Participants
|
29 Participants
|
37 Participants
|
292 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
PE, No : DA-1-SE
|
1 Participants
|
1 Participants
|
0 Participants
|
1 Participants
|
436 Participants
|
|
Number of Subjects With Different P. Falciparum Parasite Densities, by House Information and Center
PE, No : DA-2-SE
|
6 Participants
|
0 Participants
|
1 Participants
|
1 Participants
|
546 Participants
|
Adverse Events
Overall Study Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
GSK Response Center
GlaxoSmithKline
Phone: 866-435-7343
Results disclosure agreements
- Principal investigator is a sponsor employee GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
- Publication restrictions are in place
Restriction type: OTHER